
Abbott to distribute MSD’s diabetes drug in India
Abbott and MSD Pharmaceuticals have entered into a distribution agreement for MSD’s oral anti-diabetic medicine sitagliptin, its combination sitagliptin/metformin and the extended-release version in India. Leveraging its broad footprint in the country …